Background Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) has caused an infectious disease that affects multiple organs. Recently, the cardiological effects of the virus have also been striking. To the best of our knowledge, there are no SARS CoV-2 positive paediatric cases reported with sinus bradycardia in the literature. Case presentation A 14-year-old male patient presented with complaints of abdominal pain and fatigue. The heart rate of the patient, whose grandmother was found to be positive for SARS CoV-2 test, ranged between 43 and 60/min, the heart sounds were normal. There was no known history of cardiological disorder in the patient and his family. His laboratory findings were; normal Troponin I, elevated C Reactive protein, normal Haemoglobin, normal CK-MB, mildly elevated D-Dimer. Electrocardiography of the patient was evaluated as sinus bradycardia. There was no pathological finding in his echocardiography. The SARS CoV-2 PCR test was positive. In his follow-up, the heart rate decreased to 50 beats per minute while awake and 43 beats per minute while sleeping. The patient had a bradycardic course until the 4th day of hospitalisation. Control SARS CoV-2 PCR test was negative. He was discharged on the 8th day. Conclusion It's understood that SARS-CoV-2 is responsible for multiple cardiac manifestations. The most common bradyarrhythmia associated with SARS CoV-2 reported worldwide is sinus bradycardia and complete heart block. In order to contribute to the literature, we present a 14-year-old paediatric patient with positive SARS CoV-2 PCR test who has normal cardiac tests and sinus bradycardia.
Background: Food allergy is a chronic condition with psychosocial consequences for both children and their families. Strict elimination diets and fear of adverse reactions may contribute to maladaptive coping including behaviors avoidant/restrictive food intake disorder (ARFID)‐related eating patterns. Therefore, this study aimed to compare ARFID‐related eating behavior scores between children with food allergy and healthy controls and to identify the affected domains. Methods: In this prospective controlled study, 234 children aged 2–9 years were enrolled, including 117 children with physician‐diagnosed food allergy and 117 age‐ and sex‐matched healthy controls. Eating behaviors were assessed using the Nine Item Avoidant/Restrictive Food Intake Disorder Screen—Parent Report (NIAS‐PR). Total and subscale scores (picky eating, fear, and appetite) were compared between groups. Within the food allergy group, associations between clinical characteristics and NIAS‐PR scores were analyzed. Results: Children with food allergy demonstrated significantly higher NIAS‐PR total scores compared with controls. The median total NIAS score was higher in the patient group than in the control group (17 [11–24] vs. 12 [7–18], p < .001). This difference was primarily driven by higher fear‐ and picky‐eating‐related scores, whereas appetite scores did not differ significantly. Fear subscale scores were significantly higher in children with a history of urticaria or anaphylaxis. Conclusion: Pediatric food allergy is associated with increased ARFID‐related eating behaviors, particularly fear‐ and picky‐eating patterns. In addition, fear‐related scores were higher among children with a history of immediate‐type reactions, such as urticaria and anaphylaxis. These findings suggest that ARFID‐related eating behaviors should be considered in the assessment of children with food allergy.
Eritema nodozum (EN) en yaygın septal pannikülit şeklidir. Vakaların %50'sinde hiçbir neden bulunamaz. Tanımlanmış nedenlerin en önemlilerinden biri enfeksiyonlardır. Epstein-Barr virus (EBV) de nadir bir EN nedenidir. Onbeş yaşında kız hasta bir gün süren ateş ve bacaklarda daha belirgin ağrılı kızarık lezyon nedeni ile acil servise başvurdu. Fizik muayenesinde ön kol iç yüzünde ve bacaklarda en büyüğü 3*5 cm olan eritemli zemin üzerinde bulunan ağrılı nodüller dışında bulgu yoktu. Ön planda EN düşünülen hasta servise yatırıldı. Yapılan tetkiklerde tam kan sayımı normal idi. Akut faz reaktanları yüksek bulunan hastanın alınan boğaz, idrar ve kan kültürlerinde üreme saptanmadı. Etiyolojye yönelik yapılan mikrobiyolojik testlerden sadece anti-viral kapsid antijen (VCA)-IgM ve IgG testi pozitif saptandı. EBV’ye bağlı EN tanısı alan hasta semptomatik tedavi ile takip edildi. Yatışının 8. gününde ağrısı ve lezyonları gerileyen hasta taburcu edildi. EBV’nin en sık cilt bulgusu makulopapüler döküntü olsa da EN’nin saptandığı hastalarda EBV de akılda bulundurmalıdır.
Aim: This study aimed to explore clinical and laboratory markers of omalizumab response in paediatric and adult chronic spontaneous urticaria (CSU) patients. Methods: The study included 32 children and 67 adults with CSU receiving omalizumab, and 29 paediatric and 30 adult healthy controls; associations with treatment response were evaluated. Results: In adults, higher baseline Systemic Inflammation Response Index (SIRI) (OR = 0.207, p < 0.001), monocyte count (OR = 0.276, p = 0.002), neutrophil‐to‐lymphocyte ratio (NLR) (OR = 0.455, p = 0.012), and Systemic Immune‐Inflammation Index (SII) (OR = 0.487, p = 0.022) were associated with lower odds of treatment response. In paediatric patients, higher baseline SII was significantly associated with lower odds of response (OR = 0.349, p = 0.040). Interaction analyses showed nominally significant age interactions for baseline SIRI (B = −0.169, p = 0.027) and monocyte count (B = −0.193, p = 0.025). During follow‐up, SIRI was lower in responders from baseline through 12 months in adults, and at 3 and 6 months in children. SII was lower in responders at baseline in adults, and at baseline, 3, and 6 months in children (all p < 0.05). Conclusion: Our findings suggest potential differences in the associations between inflammatory markers and omalizumab response across age groups, though further studies are needed to clarify age‐related differences.